Treatment of Primary Pulmonary Hypertension with Oral Sildenafil
Authors:
- Indra NarangINIndra Narang
- Mark RosenthalMRMark Rosenthal
- Andrew BushABAndrew Bush
- Alan G. MageeAMAlan G. Magee
- 22 March 2004
- journal article
- case report
- Published by S. Karger AG in Respiration
- Vol. 71 (2) , 192-194
Abstract
Sildenafil, a selective phosphodiesterase-5 inhibitor, was administered orally to a 14-year-old girl with primary pulmonary hypertension (PPH) at a dose of 0.5 mg/kg/4 h on a daily basis, increased to doses of 1 and 2 mg/kg at monthly intervals. Following therapy, oxygen saturation increased and exercise capacity improved significantly, but with no change in pulmonary haemodynamics. No side-effects were noted. Sildenafil may be beneficial in children with PPH, but the mechanism of benefit is unclear.Keywords
This publication has 4 references indexed in Scilit:
- Sildenafil in HIV-related pulmonary hypertensionAIDS, 2001
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Haemodynamics in children during rest and exercise: methods and normal valuesEuropean Respiratory Journal, 1998
- Primary pulmonary hypertension in children: Clinical characterization and survivalJACC, 1995